FAQ/Help |
Calendar |
Search |
Today's Posts |
11-05-2008, 05:08 PM | #1 | ||
|
|||
Senior Member
|
"Overexpression of alpha-synuclein (SNCA) in families with multiplication mutations causes parkinsonism and subsequent dementia, characterized by diffuse Lewy Body disease post-mortem. Genetic variability in SNCA contributes to risk of idiopathic Parkinson's disease (PD), possibly as a result of overexpression.
SNCA downregulation is therefore a valid therapeutic target for PD. Results: We have identified human and murine-specific siRNA molecules which reduce SNCA in vitro. As a proof of concept, we demonstrate that direct infusion of chemically modified (naked), murine-specific siRNA into the hippocampus significantly reduces SNCA levels..." Here's the link: http://7thspace.com/headlines/296739...ked_sirna.html There is another article on google news but unfortunately, it's in German, which is way beyond my liguistic abilities! |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Curcumin inhibits alpha-synuclein | Parkinson's Disease | |||
the alpha-synuclein switch / worth repeat | Parkinson's Disease | |||
Research: Adding a phosphate group to mutated alpha-synuclein | Parkinson's Disease | |||
alpha-synuclein overexpression and microtubule network dysfunction | Parkinson's Disease | |||
Sirtuin 2 inhibitor, neuronal cell death and alpha synuclein | Parkinson's Disease |